British woman dies in Cyprus after AstraZeneca jab
May 26 2021
VITT is incredibly rare according to health professionals, occuring at a rate of between 1 case per 26,000 to 1 case per 127,000 doses of AstraZeneca globally.
The death is the fifth fatal case of VIIT in an AstraZeneca recipient in Canada. Experts still maintain the syndrome is exceedingly rare and treatable in most cases.
Local media said the woman, who had no history of thrombi in her vascular system, had received her first dose of the vaccine on May 6, the same day British authorities had announced people under the age of 40 in the United Kingdom were to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine. The province now has more than 300,000 doses in stock.
The first cohort of Ontarians who received the shot March reported booking headaches and a lack of clarity as they sought to schedule their second jabs on Tuesday.
Though the recommended interval between shots is at least 12 weeks, the second injection is being offered to that group after 10 weeks in order to make use of the 45,000 doses nearing expiration.
Dr. David Williams, Ontario's Medical Officer of Health, said the difference in vaccine efficacy at 10 weeks as opposed to 12 weeks is negligible.
Bates says they had to round up all 3,100 doses from across the province that is set to expire next Monday and needed to ensure no doses were spoiled.
He says if you don't get your second shot early, there's no reason to panic.
He said people should talk to their pharmacists about eligibility and some might have to wait the original 12 weeks after the province has used up the soon-to-expire vaccines. "I will be honest and say I would be slightly concerned that we don't minimise the level of changes unless there is a very clear public health argument in favour of it because the vaccination programme really is working now", he told Deputy Kelly. "The good point is that we have lots of people who are looking eager to get their second dose".
A spokeswoman for the health minister said many pharmacies and doctors would reach out to patients directly, and asked people to only contact participating pharmacies listed on the province's booking website.
Reminiscent of the first and second round registrations for the AstraZeneca Covid-19 vaccine, the third round opt-in was similarly met with several hiccups within seconds of it going "live" just after noon.
In March, South Sudan received 132,000 doses from Covax but the country's national taskforce on Covid-19 chose to return before they expire after discussing the matter with the World Health Organization (WHO).